Literature DB >> 3715814

Inhibitors of ex vivo aggregation of human platelets induced by decompression, during reduced barometric pressure.

M Murayama, K K Kumaroo.   

Abstract

It has been shown experimentally ex vivo that human platelet aggregation is induced by decompression (reduced pressure) produced by various means, i.e., reduced barometric pressure, reduced hydrostatic pressure, and reduced hydrodynamic pressure due to Bernoulli's principle. We report here that the spontaneous platelet aggregation induced by reduced barometric pressure (253 torr for three hours) is inhibited by 1:10(7) diluted Japanese herbal plant oil (JHP) and also by two of its major constituents, menthone and menthol with the median inhibitory concentration (IC50) in the millimolar range. These drugs gave essentially similar results when collagen and ADP were used as aggregating agents. Inhibitor concentrations were determined by microscopic examination of platelets in wet preparations when the aggregating stimulus was reduced pressure and by optical aggregometry when collagen and ADP were the aggregating agents. Potential usefulness of these compounds in the prevention of decompression syndrome (DCS) and acute mountain sickness (AMS) are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3715814     DOI: 10.1016/0049-3848(86)90214-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Evaluation of meteorological and epidemiological characteristics of fatal pulmonary embolism.

Authors:  Klára Törő; Rita Pongrácz; Judit Bartholy; Aletta Váradi-T; Boglárka Marcsa; Brigitta Szilágyi; Attila Lovas; György Dunay; Péter Sótonyi
Journal:  Int J Biometeorol       Date:  2015-07-17       Impact factor: 3.787

2.  Is atmospheric pressure change an Independent risk factor for hemoptysis?

Authors:  Omer Araz; Elif Yilmazel Ucar; Metin Akgun; Yener Aydin; Mehmet Meral; Leyla Saglam; Hasan Kaynar; Ali Metin Gorguner
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.